(VIANEWS) – Banc of California (BANC), AGCO (AGCO), Supernus Pharmaceuticals (SUPN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Banc of California (BANC)

18.6% sales growth and 11.71% return on equity

Banc of California, Inc. is the bank holding firm for Banc of California, National Association, which provides services and products in banking. It offers deposit products including savings, checking, money market and retirement as well as interest-bearing or non-interest-bearing demands accounts and certificate of deposits. The company also offers a variety of commercial and consumer loans, including commercial and industrial loans, multifamily and commercial real estate loans; construction loans; residential loans for single families; indirect and direct leveraged lending; mortgage loans for small businesses; and home equity loans. The company also offers remote bill payment, cash management, foreign currency, card payment and automated clearing house origination. Wire transfer, direct deposit and internet banking services are available. Master demand accounts and interest rate swaps can be arranged. It also invests in agency securities and municipal bonds as well as corporate debt securities. The company had 29 fully-service locations in Southern California as of December 31, 2020. It was previously known as First PacTrust Bancorp, Inc., but changed its name in July 2013 to Banc of California, Inc. Banc of California, Inc., was established in 1941. It is located in Santa Ana, California.

Banc of California’s sales growth this year is expected to be 28.2% and 9.4% for next year.

Year-on-year quarterly revenue growth grew by 27.4%, now sitting on 337.76M for the twelve trailing months.

Volume

Today’s last reported volume for Banc of California is 342934 which is 14.65% above its average volume of 299111.

Banc of California’s sales growth for the next quarter is 18.6%. The company’s growth estimates for the current quarter and the next is 14.3% and 642.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.71%.

Volatility

Banc of California’s last day, last week, and last month’s current intraday variation average was 2.21%, 1.08%, and 1.04%, respectively.

Banc of California’s highest amplitude of average volatility was 1.85% (day), 2.98% (last week), and 1.95% (last month), respectively.

Banc of California’s Stock Yearly Top and Bottom Value

Banc of California’s stock is valued at $17.61 at 16:22 EST, way below its 52-week high of $22.09 and above its 52-week low of $16.66.

Banc of California’s Moving Average

Banc of California’s value is higher than its 50-day moving average of $17.59 and below its 200-day moving average of $18.81.

2. AGCO (AGCO)

15.1% sales growth and 23.83% return on equity

AGCO Corporation is a distributor of agricultural equipment worldwide. AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide. It has horsepower tractors that can be used for row crop cultivation, soil cultivation and planting. It also offers grain storage containers and associated drying and handling equipment systems, seed-processing system and seed-processing equipment delivery systems. Ventilation and watering systems are available. Egg production systems as well as broiler production equipment and equipment. It also offers rectangular and round balers as well as self-propelled windrowers and loader wagons. The company also offers implements such as disc harrows that level seedbeds and add chemicals to the soils. It also provides heavy tillage which breaks up the soil and mixes crop residue with topsoil. Field cultivators are used for preparing smooth seedbeds and removing weeds. Drills can be purchased for small-grain seeding. It also offers combine harvesters for corn, wheat and soybeans; as well as application equipment such as self-propelled three- or four-wheeled vehicles and other equipment for liquid fertilizers and crop protection chemicals. Through a network independent distributors and dealers, the company sells its products under Challenger, Fendt and GSI brands. AGCO Corporation was established in 1990. It is located in Duluth in Georgia.

AGCO’s sales growth this year is expected to be 12.4% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 11.51B for the twelve trailing months.

Volume

Today’s last reported volume for AGCO is 677671 which is 14.22% above its average volume of 593259.

AGCO’s sales growth for the next quarter is 15.1%. The company’s growth estimates for the present quarter and the next is 41.1% and 25.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.83%.

Volatility

AGCO’s last day, last week, and last month’s current intraday variation average was 3.46%, 2.50%, and 1.93%, respectively.

AGCO’s highest amplitude of average volatility was 3.20% (day), 3.29% (last week), and 3.02% (last month), respectively.

AGCO’s Stock Yearly Top and Bottom Value

AGCO’s stock is valued at $104.00 at 16:22 EST, way under its 52-week high of $150.28 and way higher than its 52-week low of $88.55.

AGCO’s Moving Average

AGCO’s value is under its 50-day moving average of $104.55 and way under its 200-day moving average of $119.00.

3. Supernus Pharmaceuticals (SUPN)

13% sales growth and 7.07% return on equity

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm that focuses on developing and marketing products to treat central nervous system disorders in the United States. TrokendiXR is an extended-release topiramate product that can be used to treat epilepsy and prophylaxis for migraine headaches. OxtellarXR is an extended-release oxcarbazepine to monotherapy partial onset epilepsy in children and adults aged 6-17 years. APOKYN is a drug that treats hypomobility and off episodes in advanced Parkinson’s Disease patients. XADAGO is an adjunctive therapy to levodopa/carbidopa for patients experiencing off episodes. MYOBLOC is a type B toxin indicated to treat cervical dystonia in adults. SPN-812 is a product candidate that has been approved for use in the treatment and prevention of attention deficit hyperactivity disorder. SPN-830 is a drug/device combination candidate at late stage for the prevention or off episodes of PD. SPN-817 was a new product candidate in Phase I trials to treat severe epilepsy. SPN-820 was a product candidate in Phase I trials to treat treatment-resistant depression. It sells products via distributors and specialty pharmacies. The company has a partnership agreement with Navitor Pharmaceuticals, Inc. for a phase II clinical trial of NV-5138 in the treatment of depressive disorder. Rockville, Maryland is the headquarters of this company. It was established in 2005.

Supernus Pharmaceuticals’s sales growth this year is expected to be 16.5% and a negative 10.1% for next year.

Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 630.07M for the twelve trailing months.

Volume

Today’s last reported volume for Supernus Pharmaceuticals is 192727 which is 46.67% below its average volume of 361453.

Supernus Pharmaceuticals’s sales growth for the next quarter is 13%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.07%.

Volatility

Supernus Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 1.89%, 1.49%, and 1.77%, respectively.

Supernus Pharmaceuticals’s highest amplitude of average volatility was 3.45% (day), 3.23% (last week), and 3.68% (last month), respectively.

Supernus Pharmaceuticals’s Stock Yearly Top and Bottom Value

Supernus Pharmaceuticals’s stock is valued at $34.39 at 16:22 EST, under its 52-week high of $36.08 and way above its 52-week low of $24.95.

Supernus Pharmaceuticals’s Moving Average

Supernus Pharmaceuticals’s worth is higher than its 50-day moving average of $31.58 and way higher than its 200-day moving average of $30.28.

4. Terreno Realty Corporation (TRNO)

12.9% sales growth and 8.89% return on equity

Terreno Realty Corporation, together with its subsidiaries, is the A “CompanyA” that acquires, owns, and operates industrial real property in six key coastal U.S. cities: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, Washington, D.C. The Company had 219 buildings totaling about 13.1 Million Square Feet, 22 improved land parcels of around 85.0 Acres, and one property in a redevelopment process that will contain an estimated 0.2 Mio. square feet. As a Maryland corporation, the Company has elected to tax itself as an investment trust in real estate (A’REITA) under Sections 856-860 of The Internal Revenue Code of 1986 (as amended). This will apply from its taxable year ending December 31, 2010.

Terreno Realty Corporation’s sales growth this year is expected to be 19.2% and 9% for next year.

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 247.35M for the twelve trailing months.

Volume

Today’s last reported volume for Terreno Realty Corporation is 449926 which is 9.97% above its average volume of 409129.

Terreno Realty Corporation’s sales growth for the next quarter is 12.9%. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.89%.

Volatility

Terreno Realty Corporation’s last day, last week, and last month’s current intraday variation average was 2.81%, 2.08%, and 1.36%, respectively.

Terreno Realty Corporation’s highest amplitude of average volatility was 3.24% (day), 2.40% (last week), and 2.10% (last month), respectively.

Terreno Realty Corporation’s Stock Yearly Top and Bottom Value

Terreno Realty Corporation’s stock is valued at $60.24 at 16:22 EST, way under its 52-week high of $86.00 and way higher than its 52-week low of $54.51.

Terreno Realty Corporation’s Moving Average

Terreno Realty Corporation’s worth is under its 50-day moving average of $61.20 and way below its 200-day moving average of $68.47.

5. Acadia Healthcare Company (ACHC)

11.4% sales growth and 10.99% return on equity

Acadia Healthcare Company, Inc. is a developer and operator of inpatient and residential psychiatric centers, group homes, substance-abuse facilities, outpatient behavioral healthcare and treatment facilities. These facilities are used to meet the needs of the communities throughout the United States, Puerto Rico, and other countries. It operates an acute inpatient mental health facility that stabilizes patients who are vulnerable to suicide or need 24-hour monitoring, intervention and supervision by psychiatrists. The company also has specialty treatment facilities that include residential treatment and eating disorder facilities and holistic treatment centers which provide continuous care for people with co-occurring mental and addictive disorders. The company also offers residential treatment centers that treat behavioral disorders and provide therapeutic placements for adolescents and children with emotional disorders. It had approximately 10500 beds in 228 of its behavioral health facilities as of February 28, 2022. Acadia Healthcare Company, Inc. is located in Franklin, Tennessee.

Acadia Healthcare Company’s sales growth this year is expected to be 11.7% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 2.45B for the twelve trailing months.

Volume

Today’s last reported volume for Acadia Healthcare Company is 549757 which is 6.5% below its average volume of 588033.

Acadia Healthcare Company’s sales growth is a negative 0% for the present quarter and 11.4% for the next. The company’s growth estimates for the current quarter and the next is 9.7% and 16.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.99%.

Volatility

Acadia Healthcare Company’s last day, last week, and last month’s current intraday variation average was 0.49%, 1.80%, and 1.38%, respectively.

Acadia Healthcare Company’s highest amplitude of average volatility was 2.81% (day), 2.69% (last week), and 2.73% (last month), respectively.

Acadia Healthcare Company’s Stock Yearly Top and Bottom Value

Acadia Healthcare Company’s stock is valued at $83.89 at 16:23 EST, below its 52-week high of $86.75 and way above its 52-week low of $50.07.

Acadia Healthcare Company’s Moving Average

Acadia Healthcare Company’s value is above its 50-day moving average of $80.17 and way higher than its 200-day moving average of $67.35.

6. PCB Bancorp (PCB)

10.4% sales growth and 14.31% return on equity

PCB Bancorp is the bank holding firm for Pacific City Bank. It provides a variety of banking products and services to both individuals and businesses within the small and medium market in Southern California. It offers time, demand, savings and money market deposits as well as certificates and deposit. Remote deposit capture is available, along with courier deposit services and positive pay. Zero balance accounts are also offered. The company also offers real estate loans and commercial and industrial loans. It also offers unsecured and secured lines of credit for automobiles, term loans and loans to individuals. This includes business loans such as manufacturing, wholesale, retail, hospitality and other types. The company also offers automated teller machines and debit cards as well as cashier’s and wire transfers, treasury management and wire transfer and automated clearinghouse services. It also provides cash management and services online, by telephone and mail. The company operates via a network that includes 11 fully-service branches located in Los Angeles, Orange, and Bayside counties in California, as well as a branch in Englewood Cliffs and Bayside in New Jersey. There are 9 loan production centers that the company operates in Irvine, Artesia and Los Angeles, California, Annandale and Virginia, Chicago, Illinois, Bellevue and Washington, Aurora and Colorado, Carrollton and Texas, as well as New York, New York. The former name of the company was Pacific City Financial Corporation. In July 2019, it changed its name from PCB Bancorp to PCB Bancorp. PCB Bancorp is located in Los Angeles and was established in 2003.

PCB Bancorp’s sales growth this year is anticipated to be 11.6% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 104.84M for the twelve trailing months.

Volume

Today’s last reported volume for PCB Bancorp is 25766 which is 65.55% below its average volume of 74793.

PCB Bancorp’s sales growth for the next quarter is 10.4%. The company’s growth estimates for the present quarter and the next is a negative 6.8% and negative -11.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.31%.

Volatility

PCB Bancorp’s last day, last week, and last month’s current intraday variation average was 1.40%, 0.92%, and 0.89%, respectively.

PCB Bancorp’s highest amplitude of average volatility was 1.78% (day), 1.77% (last week), and 1.87% (last month), respectively.

PCB Bancorp’s Stock Yearly Top and Bottom Value

PCB Bancorp’s stock is valued at $18.77 at 16:23 EST, way below its 52-week high of $26.04 and higher than its 52-week low of $17.96.

PCB Bancorp’s Moving Average

PCB Bancorp’s worth is below its 50-day moving average of $19.10 and way under its 200-day moving average of $21.20.

7. Heritage-Crystal Clean (HCCI)

8.2% sales growth and 20.73% return on equity

Heritage-Crystal Clean, Inc., via its subsidiary Heritage-Crystal Clean, LLC, offers parts cleaning, hazardous, and non-hazardous material waste collection and oil collection services for small and medium-sized clients in the automotive and industrial maintenance industries in Canada and the United States. The company operates in two areas: Environmental Services and Oil Business. Environmental Services includes parts cleaning, antifreeze recycling and wastewater vacuum. Oil Business is involved in oil collection, oil recycling, oil filter removal, disposal, and re-refinement of oil to make lubricant base oils and other products. It also disposes of wastewater. It had 91 branches that served approximately 95,000 customers as of January 1, 2022. Heritage-Crystal Clean, Inc., was founded in 2007. It is located in Elgin, Illinois.

Heritage-Crystal Clean’s sales growth this year is expected to be 12.7% and 2.9% for next year.

Year-on-year quarterly revenue growth grew by 33.6%, now sitting on 588.69M for the twelve trailing months.

Volume

Today’s last reported volume for Heritage-Crystal Clean is 100173 which is 17.48% below its average volume of 121393.

Heritage-Crystal Clean’s sales growth is a negative 0% for the present quarter and 8.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 21.9% and negative -30.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.73%.

Volatility

Heritage-Crystal Clean’s last day, last week, and last month’s current intraday variation average was 0.31%, 1.34%, and 1.56%, respectively.

Heritage-Crystal Clean’s highest amplitude of average volatility was 2.23% (day), 2.47% (last week), and 2.68% (last month), respectively.

Heritage-Crystal Clean’s Stock Yearly Top and Bottom Value

Heritage-Crystal Clean’s stock is valued at $32.57 at 16:23 EST, way under its 52-week high of $36.29 and way above its 52-week low of $24.00.

Heritage-Crystal Clean’s Moving Average

Heritage-Crystal Clean’s value is above its 50-day moving average of $30.50 and way above its 200-day moving average of $29.58.

8. Gladstone Commercial Corporation (GOOD)

6.9% sales growth and 3.46% return on equity

Gladstone Commercial Corporation, a real-estate investment trust, focuses on the acquisition, ownership, and operation of net leased office and industrial properties in the United States. Gladstone Commercial’s common stock has received 189 monthly cash dividends, including payments up to September 2020. Gladstone Commercial had previously paid five consecutive quarterly cash dividends before it began paying monthly distributions. Gladstone Commercial has paid 52 consecutive monthly cash dividends on Series D Preferred stock, 12 consecutive monthly cash payments on Series E Preferred stock and three consecutive monthly cash payouts on Series F Preferred stock. Gladstone Commercial never missed, decreased or delayed a distribution from its inception in 2003.

Gladstone Commercial Corporation’s sales growth this year is expected to be 5.8% and 5.6% for next year.

Year-on-year quarterly revenue growth grew by 2.5%, now sitting on 138.54M for the twelve trailing months.

Volume

Today’s last reported volume for Gladstone Commercial Corporation is 108165 which is 47.86% below its average volume of 207476.

Gladstone Commercial Corporation’s sales growth for the next quarter is 6.9%. The company’s growth estimates for the current quarter and the next is 100% and negative -100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.46%.

Volatility

Gladstone Commercial Corporation’s last day, last week, and last month’s current intraday variation average was 2.61%, 1.25%, and 1.25%, respectively.

Gladstone Commercial Corporation’s highest amplitude of average volatility was 3.45% (day), 2.02% (last week), and 1.90% (last month), respectively.

Gladstone Commercial Corporation’s Stock Yearly Top and Bottom Value

Gladstone Commercial Corporation’s stock is valued at $19.16 at 16:23 EST, way under its 52-week high of $26.13 and above its 52-week low of $17.73.

Gladstone Commercial Corporation’s Moving Average

Gladstone Commercial Corporation’s worth is under its 50-day moving average of $19.58 and way under its 200-day moving average of $21.39.

LEAVE A REPLY

Please enter your comment!
Please enter your name here